Biocon Gelecekteki Büyüme
Future kriter kontrolleri 2/6
Biocon kazanç ve gelirin sırasıyla yıllık 6.8% ve 14.8% oranında artacağı tahmin edilmektedir. EPS'nin yıllık 7.4% oranında büyümesi beklenmektedir. Özkaynak kârlılığının 3 yıl içinde 6% olacağı tahmin edilmektedir.
Anahtar bilgiler
6.8%
Kazanç büyüme oranı
7.4%
EPS büyüme oranı
Biotechs kazanç büyümesi | 49.3% |
Gelir büyüme oranı | 14.8% |
Gelecekteki özkaynak getirisi | 6.0% |
Analist kapsamı | Good |
Son güncelleme | 20 Nov 2024 |
Gelecekteki son büyüme güncellemeleri
Here's What Analysts Are Forecasting For Biocon Limited (NSE:BIOCON) After Its Second-Quarter Results
Nov 02Biocon Limited Just Beat EPS By 240%: Here's What Analysts Think Will Happen Next
Feb 12Recent updates
Here's What Analysts Are Forecasting For Biocon Limited (NSE:BIOCON) After Its Second-Quarter Results
Nov 02Why Investors Shouldn't Be Surprised By Biocon Limited's (NSE:BIOCON) Low P/E
Nov 01Do Biocon's (NSE:BIOCON) Earnings Warrant Your Attention?
Oct 14These 4 Measures Indicate That Biocon (NSE:BIOCON) Is Using Debt Extensively
Sep 20Biocon Limited's (NSE:BIOCON) Earnings Haven't Escaped The Attention Of Investors
Jun 29Is Biocon (NSE:BIOCON) A Risky Investment?
Jun 11Biocon (NSE:BIOCON) Is Reducing Its Dividend To ₹0.50
Jun 11Biocon's (NSE:BIOCON) Promising Earnings May Rest On Soft Foundations
May 24Biocon's (NSE:BIOCON) Dividend Is Being Reduced To ₹0.50
May 23Is Now The Time To Put Biocon (NSE:BIOCON) On Your Watchlist?
Mar 20Biocon Limited Just Beat EPS By 240%: Here's What Analysts Think Will Happen Next
Feb 12Biocon Limited's (NSE:BIOCON) Intrinsic Value Is Potentially 18% Below Its Share Price
Jan 23Shareholders Should Be Pleased With Biocon Limited's (NSE:BIOCON) Price
Jan 03These 4 Measures Indicate That Biocon (NSE:BIOCON) Is Using Debt Extensively
Nov 13Estimating The Intrinsic Value Of Biocon Limited (NSE:BIOCON)
Aug 03Biocon (NSE:BIOCON) Will Pay A Larger Dividend Than Last Year At ₹1.50
Jul 03Is Biocon (NSE:BIOCON) Using Too Much Debt?
Jul 02Biocon's (NSE:BIOCON) Dividend Will Be Increased To ₹1.50
May 26Estimating The Fair Value Of Biocon Limited (NSE:BIOCON)
Mar 28Here's Why Biocon (NSE:BIOCON) Can Manage Its Debt Responsibly
Feb 26Biocon Limited (NSE:BIOCON) Shares Could Be 24% Above Their Intrinsic Value Estimate
Dec 17Is There An Opportunity With Biocon Limited's (NSE:BIOCON) 46% Undervaluation?
Sep 05Is Biocon (NSE:BIOCON) Using Too Much Debt?
Jul 13Biocon Limited (NSE:BIOCON) Shares Could Be 20% Below Their Intrinsic Value Estimate
May 26Kazanç ve Gelir Büyüme Tahminleri
Tarih | Gelir | Kazançlar | Serbest Nakit Akışı | Faaliyetlerden Nakit | Avg. Analist Sayısı |
---|---|---|---|---|---|
3/31/2027 | 211,455 | 16,508 | 26,576 | 40,003 | 14 |
3/31/2026 | 183,294 | 12,148 | 22,177 | 36,138 | 18 |
3/31/2025 | 153,789 | 11,172 | 16,571 | 34,415 | 17 |
9/30/2024 | 148,941 | 14,392 | 21,045 | 40,368 | N/A |
6/30/2024 | 147,660 | 15,808 | N/A | N/A | N/A |
3/31/2024 | 147,557 | 10,225 | 10,223 | 29,539 | N/A |
12/31/2023 | 146,125 | 12,002 | N/A | N/A | N/A |
9/30/2023 | 135,999 | 4,984 | -6,241 | 11,717 | N/A |
6/30/2023 | 124,573 | 4,197 | N/A | N/A | N/A |
3/31/2023 | 111,742 | 4,627 | 1,262 | 18,525 | N/A |
12/31/2022 | 98,091 | 3,881 | N/A | N/A | N/A |
9/30/2022 | 90,422 | 6,170 | -6,836 | 11,543 | N/A |
6/30/2022 | 85,629 | 7,084 | N/A | N/A | N/A |
3/31/2022 | 81,840 | 6,484 | -7,482 | 11,766 | N/A |
12/31/2021 | 75,800 | 6,727 | N/A | N/A | N/A |
9/30/2021 | 72,632 | 6,542 | -6,366 | 12,763 | N/A |
6/30/2021 | 71,726 | 6,852 | N/A | N/A | N/A |
3/31/2021 | 71,431 | 7,405 | -5,866 | 11,597 | N/A |
12/31/2020 | 68,913 | 5,996 | N/A | N/A | N/A |
9/30/2020 | 67,571 | 6,362 | -6,576 | 10,484 | N/A |
6/30/2020 | 65,796 | 6,870 | N/A | N/A | N/A |
3/31/2020 | 63,005 | 7,771 | -5,534 | 12,831 | N/A |
12/31/2019 | 63,150 | 8,385 | N/A | N/A | N/A |
9/30/2019 | 61,077 | 8,529 | -3,416 | 14,573 | N/A |
6/30/2019 | 58,565 | 9,919 | N/A | N/A | N/A |
3/31/2019 | 55,144 | 9,053 | -3,374 | 11,546 | N/A |
12/31/2018 | 51,551 | 8,220 | N/A | N/A | N/A |
9/30/2018 | 46,722 | 6,967 | N/A | N/A | N/A |
6/30/2018 | 43,198 | 4,108 | N/A | N/A | N/A |
3/31/2018 | 41,234 | 3,724 | N/A | 6,621 | N/A |
12/31/2017 | 38,792 | 3,695 | N/A | N/A | N/A |
9/30/2017 | 38,589 | 4,489 | N/A | N/A | N/A |
6/30/2017 | 38,361 | 5,268 | N/A | N/A | N/A |
3/31/2017 | 38,911 | 6,121 | N/A | 6,400 | N/A |
12/31/2016 | 40,487 | 11,633 | N/A | N/A | N/A |
9/30/2016 | 38,110 | 10,961 | N/A | N/A | N/A |
6/30/2016 | 36,539 | 9,388 | N/A | N/A | N/A |
3/31/2016 | 33,474 | 5,504 | N/A | 3,706 | N/A |
12/31/2015 | 32,997 | 7,367 | N/A | N/A | N/A |
9/30/2015 | 32,325 | 7,247 | N/A | N/A | N/A |
6/30/2015 | 31,528 | 5,207 | N/A | N/A | N/A |
3/31/2015 | 30,898 | 4,974 | N/A | 2,107 | N/A |
12/31/2014 | 29,807 | 4,091 | N/A | N/A | N/A |
9/30/2014 | 29,168 | 4,231 | N/A | N/A | N/A |
6/30/2014 | 29,014 | 4,232 | N/A | N/A | N/A |
3/31/2014 | 28,773 | 4,138 | N/A | 5,607 | N/A |
12/31/2013 | 28,180 | 5,493 | N/A | N/A | N/A |
Analist Gelecek Büyüme Tahminleri
Kazançlar ve Tasarruf Oranları: BIOCON 'nin tahmini kazanç büyümesi (yıllık 6.8% ) tasarruf oranının ( 6.7% ) üzerindedir.
Kazançlar ve Piyasa: BIOCON şirketinin kazançlarının (yıllık 6.8% ) Indian pazarından (yıllık 18% ) daha yavaş büyümesi öngörülüyor.
Yüksek Büyüme Kazançları: BIOCON şirketinin kazançlarının artması bekleniyor, ancak önemli ölçüde.
Gelir ve Pazar: BIOCON şirketinin gelirinin (yıllık 14.8% ) Indian pazarından (yıllık 10.5% ) daha hızlı büyümesi öngörülüyor.
Yüksek Büyüme Geliri: BIOCON şirketinin gelirinin (yıllık 14.8% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.
Hisse Başına Kazanç Büyüme Tahminleri
Gelecekteki Özkaynak Getirisi
Gelecekteki ROE: BIOCON 'nin Özsermaye Getirisi'nin 3 yıl içinde düşük olması tahmin ediliyor ( 6 %).